Why doesn't reducing exacerbations decrease COPD mortality?
Author:
- 1 September 2014
- journal article
- Published by Elsevier in The Lancet Respiratory Medicine
- Vol. 2 (9) , 681-683
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation StudyPLOS ONE, 2014
- Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification: A Study of the General PopulationAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Changes in Forced Expiratory Volume in 1 Second over Time in COPDNew England Journal of Medicine, 2011
- Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their BiomarkersAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2010
- Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPDAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Outcomes for COPD pharmacological trials: from lung function to biomarkersEuropean Respiratory Journal, 2008
- COPD exacerbations: defining their cause and preventionThe Lancet, 2007
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002
- Toward a Consensus Definition for COPD ExacerbationsChest, 2000